Professor Anders Soegaard, Natural Language Processing and Machine Learning, Dept. Computer Science, University of Copenhagen. He is an international top researcher and as previously been working with Amazon and Google Research.
He is one of the most published
researchers in the field of NLP in Denmark.
Dr. Josephine Klitgaard, Translational Genomics and Cancer Therapy, Department of Medical Oncology, Dana-Farber Institute, Harvard Medical School. Dr. Klitgaard is an expert on cancer genome analyses with a particular focus on therapeutics in leukemia. She did her postdoctoral fellowship in the lab of Jennifer Brown at Dana-Farber Cancer Institute, HMS and Broad Institute.
Dr. Anders Kofod-Petersen is Professor of Applied Artificial Intelligence at the Norwegian University of Science and Technology and private consultant for industry. His work revolves around turning invention into innovation in artificial intelligence. He has worked with both academic research and industry implementation for more than 20 years. His primary research interests are on knowledge-intensive systems, cognitive science and explainability.
Dr. Minyi Lu, MD, PhD, Global Evidence Generation Leader, GE Healthcare Pharmaceutical Diagnostics. Before joining the pharmaceutical industry, Dr. Lu served as Assistant Professor at Tuft University Medical School and Senior Biostatistician and Epidemiologist at Tufts medical Center Institute for Clinical Research and Health Policy Studies.
Dr. Ingrid Harbo, VP Biometrics, H. Lundbeck A/S. Dr. Harbo wrote her PhD in biostatistics and has more than two decades of experience with biostatistics and biometrics. She has experience with research in both academia and in industry,
currently being a chairperson for
Erhvervsforsker-udvalget in Innovation Fund Denmark as well as a member of the SCIENCE advisory board at University of Copenhagen.
Professor Morten Andersen, Pharmacovigilance at Department of Drug Design and Pharmacology, University of Copenhagen. Professor Andersen has spent more than a decade in research at both University of Southern Denmark (SDU) and Karolinska Institutet, where he also was a visiting professor. He is specialized in pharmacology and pharma-epidemiology, and is now a professor at University of Copenhagen.